Angiotensin II-induced ERK1/ERK2 activation and protein synthesis are redox-dependent in glomerular mesangial cells
Gorin, Yves, Ricono, Jill M, Wagner, Brent, Kim, Nam-Ho, Bhandari, Basant, Choudhury, Goutam Ghosh, Abboud, Hanna E
Published in Biochemical journal (01.07.2004)
Published in Biochemical journal (01.07.2004)
Get full text
Journal Article
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
LUO, Jun-Li, WEI TAN, RICONO, Jill M, KORCHYNSKYI, Olexandr, MING ZHANG, GONIAS, Steven L, CHERESH, David A, KARIN, Michael
Published in Nature (London) (05.04.2007)
Published in Nature (London) (05.04.2007)
Get full text
Journal Article
Transient exposure to quizartinib mediates sustained inhibition of FLT3 signaling while specifically inducing apoptosis in FLT3-activated leukemia cells
Gunawardane, Ruwanthi N, Nepomuceno, Ronald R, Rooks, Allison M, Hunt, Jeremy P, Ricono, Jill M, Belli, Barbara, Armstrong, Robert C
Published in Molecular cancer therapeutics (01.04.2013)
Published in Molecular cancer therapeutics (01.04.2013)
Get full text
Journal Article
Reciprocal Induction of Simple Organogenesis by Mouse Kidney Progenitor Cells in Three-Dimensional Co-Culture
Velagapudi, Chakradhar, Nilsson, Rune-Par, Lee, Myung Ja, Burns, Hannah S, Ricono, Jill M, Arar, Mazen, Barnes, Veronique L, Abboud, Hanna E, Barnes, Jeffrey L
Published in The American journal of pathology (01.02.2012)
Published in The American journal of pathology (01.02.2012)
Get full text
Journal Article
Mitogenic signaling via platelet-derived growth factor β in metanephric mesenchymal cells
WAGNER, Brent, RICONO, Jill M, GORIN, Yves, BLOCK, Karen, ARAR, Mazen, RILEY, Dan, GHOSH CHOUDHURY, Goutam, ABBOUD, Hanna E
Published in Journal of the American Society of Nephrology (01.11.2007)
Published in Journal of the American Society of Nephrology (01.11.2007)
Get full text
Journal Article
Arachidonic acid-dependent activation of a p22(phox)-based NAD(P)H oxidase mediates angiotensin II-induced mesangial cell protein synthesis and fibronectin expression via Akt/PKB
Block, Karen, Ricono, Jill M, Lee, Duck-Yoon, Bhandari, Basant, Choudhury, Goutam Ghosh, Abboud, Hanna E, Gorin, Yves
Published in Antioxidants & redox signaling (01.09.2006)
Published in Antioxidants & redox signaling (01.09.2006)
Get more information
Journal Article
Nuclear cytokine-activated IKKα controls prostate cancer metastasis by repressing Maspin
Luo, Jun-Li, Tan, Wei, Ricono, Jill M, Korchynskyi, Olexandr, Zhang, Ming, Gonias, Steven L, Cheresh, David A, Karin, Michael
Published in Nature (London) (12.02.2009)
Published in Nature (London) (12.02.2009)
Get full text
Journal Article
Fibronectin induces ureteric bud cells branching and cellular cord and tubule formation
Ye, Peng, Habib, Samy L., Ricono, Jill M., Kim, Nam-Ho, Choudhury, Goutam G., Barnes, Jeffrey L., Abboud, Hanna E., Arar, Mazen Y.
Published in Kidney international (01.10.2004)
Published in Kidney international (01.10.2004)
Get full text
Journal Article
Specific Cross-talk between Epidermal Growth Factor Receptor and Integrin αvβ5 Promotes Carcinoma Cell Invasion and Metastasis
RICONO, Jill M, HUANG, Miller, BARNES, Leo A, LAU, Steven K, WEIRS, Sara M, SCHLAEPFER, David D, HANKS, Steven K, CHERESH, David A
Published in Cancer research (Chicago, Ill.) (15.02.2009)
Published in Cancer research (Chicago, Ill.) (15.02.2009)
Get full text
Journal Article
Morphological Insights into the Origin of Glomerular Endothelial and Mesangial Cells and Their Precursors
Ricono, Jill M, Xu, Yi-Chun, Arar, Mazen, Jin, Dong-chan, Barnes, Jeffrey L, Abboud, Hanna E
Published in The journal of histochemistry and cytochemistry (01.02.2003)
Published in The journal of histochemistry and cytochemistry (01.02.2003)
Get full text
Journal Article
Abstract 2640: HBI-2375, a first-in-class IND ready selective MLL1-WDR5 inhibitor, retains desirable preclinical characteristics in solid tumors and in leukemias to be pursued in clinical studies
Shojaei, Farbod, Fang, Che, Ricono, Jill M., Gillings, Mireille
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article
Abstract C071: HBI-2375, a selective inhibitor of MLL1-WDR5 interaction, possesses desirable preclinical characteristics in solid tumors in combination with checkpoint inhibitors and also in leukemias in the future clinical investigations
Shojaei, Farbod, Fang, Che, Ricono, Jill M, Gillings, Mireille
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Increased Effect of Interferon γ on PDGF-Induced c-fos Gene Transcription in Glomerular Mesangial Cells: Differential Effect of the Transcriptional Coactivator CBP on STAT1α Activation
Ghosh Choudhury, Goutam, Ricono, Jill M
Published in Biochemical and biophysical research communications (14.07.2000)
Published in Biochemical and biophysical research communications (14.07.2000)
Get full text
Journal Article
Abstract A098: HBI-2376, HUYABIO clinical stage SHP2 inhibitor, displays efficacy signal in patients with KRAS mutations in early clinical studies
Shojaei, Farbod, Ricono, Jill M, Fang, Che, Xing, Yan, Ning, John, Lee, Gloria, Gillings, Mireille
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract A097: HBI-2438, HUYABIO selective KRASG12C inhibitor with BBB penetration, inhibited tumor growth in a metastatic brain model as single agent and also displayed synergy in combination with HBI-2376 (HUYABIO SHP2 inhibitor) in a CRC PDX model
Shojaei, Farbod, Ricono, Jill M, Fang, Che, Ning, John, Lee, Gloria, Gillings, Mireille
Published in Molecular cancer therapeutics (01.12.2023)
Published in Molecular cancer therapeutics (01.12.2023)
Get full text
Journal Article
Abstract 1041: HBI-2376, HUYABIO clinical stage SHP2 inhibitor, possess robust in vitro potency and in vivo efficacy in several preclinical tumor models carrying KrasG12C or EGFR mutations
Shojaei, Farbod, Ricono, Jill M., Fang, Che, Kabbinavar, Fairooz, Goodenow, Bob, Gillings, Mireille
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
Abstract LB526: HBI-2375, a selective inhibitor of MLL1-WDR5 interaction, possesses desirable preclinical characteristics to be pursued in IND enabling studies and future clinical investigations
Shojaei, Farbod, Semple, J E., Fang, Che, Ricono, Jill M., Kabbinavar, Fairooz, Goodenow, Bob, Gillings, Mireille
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article